Vanguard Group »

Aspire Biopharma Hldgs shares owned by Vanguard Group

Quarter-by-quarter ownership of Aspire Biopharma Hldgs (ASBP) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Aspire Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $88k 429k 0.21

More positions owned by Vanguard Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Oracle Corporation (ORCL)

View all positions for Vanguard Group

Top funds holding Aspire Biopharma Hldgs

Crewe Advisors
Procyon Private Wealth Partners
Vanguard Group
Optivise Advisory Services
Geode Capital Management
Antara Capital
VR Advisory Services
Resolute Advisors
Three Seasons Wealth
P. Schoenfeld Asset Management
Efficient Wealth Management
Periscope Capital
Atlantic Trust
Hallmark Capital Management
Platform Technology Partners

View all funds holding Aspire Biopharma Hldgs